Pharmaceuticals

Telehealth Medical Research Healthcare Regulation Pharmaceutical Policy Clinical Research Studies Clinical Studies Risk Factors Emergency Services Regulatory Authority

FDA Approves Twice-Yearly HIV Prevention Shot Lenacapavir

High US pricing threatens access despite Gilead’s deals for low-cost generics in 120 low-income countries.

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Stories older than 24h

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

Hims & Hers to Acquire Zava, Adding 1.3M Customers in Europe

US Teen Wegovy Prescriptions Jump 50% in 2024 and Reach 17.3 per 100,000 by March 2025

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death

Experimental ALS Drug Shows Unprecedented Effects in Rare Genetic Cases

Trump Administration Begins Enforcing Prescription Drug Price Controls

Study Links Combined Oral Contraceptives to Tripled Risk of Cryptogenic Stroke in Young Women

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

San Jose Fire Captain Charged with Tampering and Stealing Emergency Narcotics

Trump's Executive Order Enacts Global Benchmark for U.S. Drug Prices

Spotify Struggles to Curb Fake Podcasts Promoting Illegal Prescription Drug Sales

Novo Nordisk CEO Steps Down Following Share Price Collapse

Rep. Ro Khanna Files Legislation to Codify Trump’s Drug Pricing Executive Order

Trump’s Executive Order Targets Prescription Drug Prices and PBMs

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

Trump’s Executive Order Targets U.S. Drug Prices with Foreign Rate Parity